|

Biomarker Profiling in Abdominal Aortic Aneurysm Patients

RECRUITINGSponsored by Erasmus Medical Center
Actively Recruiting
SponsorErasmus Medical Center
Started2017-03-23
Est. completion2024-08
Eligibility
Age18 Years+
View on ClinicalTrials.gov →

NCT03703947

Summary

The BIOMArCS-AAA study aims to investigate the associations of (temporal patterns of) blood biomarkers with aneurysm growth in patients with abdominal aortic aneurysm (AAA), with particular attention to biomarkers that have demonstrated prognostic value for adverse disease outcomes in coronary artery disease and biomarkers for the main genetic pathways associated with AAA.

Eligibility

Age: 18 Years+
Inclusion Criteria:

* Age of 18 years or older
* Capable of understanding and signing informed consent AND one of the following

  1. Diagnosis of AAA, with a diameter ≥40mm, based on any imaging technique and treated by watchful waiting strategy (Prospective longitudinal study, Arm 1 watchful waiting group)
  2. Planned to undergo EVAR for AAA (Prospective longitudinal study, Arm 2 EVAR group)
  3. Underwent EVAR for AAA in past years (Cross-sectional study)

Exclusion Criteria:

* Patients with isolated iliac artery aneurysm, traumatic aneurysm, anastomotic aneurysm and infectious aneurysm
* Patients with a clinical diagnosed thoracic aneurysm (i.e. located in the chest, above the diaphragm)
* Coexistent condition with life expectancy ≤ 1 year
* Dialysis dependent, (end stage) renal disease patients
* Women of childbearing age
* Linguistic barrier
* Unlikely to appear at all scheduled follow-up visits

Conditions2

Abdominal Aortic AneurysmHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.